The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2435-2441

  Couck, Marijke De ^a   Brummelen, David Van ^b   Schallier, Denis ^b   Grève, Jacques De ^b   Gidron, Yori ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cancer prognosis; Early diagnosis; Heart rate variability; Neuromodulation; Predictive factor

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CARDIAC PATIENT; CONTROLLED STUDY; HEART RATE VARIABILITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SURVIVAL TIME; VAGUS NERVE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HEART RATE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84884160022     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2725     Document Type: Article

References (49)

1. Global cancer statistics: CA Cancer J Clin 61: 69-90, 2011.
2. Eastham JA: Prostate-specific antigen doubling time as a prognostic marker in prostate cancer. Nat Clin Pract Urol 2: 482-491, 2005.
3. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM and Scher HI; COU-AA-301 Investigators: Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364: 1995-2005, 2011.
4. Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D'Amico TA and Boyd JA: Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 115: 5218-5227, 2009.
5. Rosell R, Molina MA, Costa C, Simonetti S, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Moran T, Mendez P, Cardenal F, Isla D, Provencio M, Cobo M, Insa A, Garcia-Campelo R, Reguart N, Majem M, Viteri S, Carcereny E, Porta R, Massuti B, Queralt C, de Aguirre I, Sanchez JM, Sanchez-Ronco M, Mate JL, Ariza A, Benlloch S, Sanchez JJ, Bivona TG, Sawyers CL and Taron M: Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. Clin Cancer Res 17: 1160-1168, 2011.
6. Gandhi L and Janne PA: Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target. Clin Cancer Res 18: 3737-3742, 2012.
7. Brundage MD, Davies D and Mackillop WJ: Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122: 1037-1057, 2002.
8. Marijon H, Bouyon A, Vignot S and Besse B: Prognostic and predictive factors in lung cancer. Bull Cancer 96: 391-404, 2009.
9. Lee JH, Song EM, Sim YS, Ryu YJ and Chang JH: Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol 6: 305-309, 2011.
10. Valko M, Izakovic M, Mazur M, Rhodes CJ and Telser J: Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37-56, 2004.
11. Faux SP, Tai T, Thorne D, Xu Y, Breheny D and Gaca M: The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14: 90-96, 2009.
12. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H and Rusyn I: Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol 14: 1182-1190, 2007.
13. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
14. Voronov E, Shouval DS, Krelin Y, et al: IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645-2650, 2003.
15. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
16. Entschladen F, Drell TL IV, Lang K, Joseph J and Zaenker KS: Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol 5: 254-258, 2004.
17. Tracey KJ: Reflex control of immunity. Nat Rev Immunol 9: 418-428, 2009.
18. Ek M, Kurosawa M, Lundeberg T and Ericsson A: Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18: 9471-9479, 1998.
19. Pavithran P, Nandeesha H, Sathiyapriya V, Bobby Z and Madanmohan T: Short-term heart variability and oxidative stress in newly diagnosed essential hypertension. Clin Exp Hypertens 30: 486-496, 2009.
20. Vlcek M, Radikova Z, Penesova A, et al: Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton Neurosci 143: 53-57, 2008.
21. De Couck M, Mravec B and Gidron Y: You may need the vagus nerve to understand pathophysiology and to treat diseases. Clin Sci 122: 323-328, 2012.
22. Gidron Y, Perry H and Glennie M: Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol 6: 245-248, 2005.
23. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065, 1996.
24. Kuo TB, Lai C J, Huang YT and Yang CC: Regression analysis between heart rate variability and baroreflex-related vagus nerve activity in rats. J Cardiovasc Electrophysiol 16: 864-869, 2005.
25. Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R and Maisch B: Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 63: 35-42, 2001.
26. Fadul N, Strasser F, Palmer LJ, Yusuf SW, Guo Y, Li Z, Allo J and Bruera E: The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage 39: 283-290, 2010.
27. Chiang JK, Koo M, Kuo TB and Fu CH: Association between cardiovascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma. J Pain Symptom Manage 39: 673-679, 2010.
28. Kim do H, Kim JA, Choi YS, Kim SH, Lee JY and Kim YE: Heart rate variability and length of survival in hospice cancer patients. J Korean Med Sci 25: 1140-1145, 2010.
29. Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A and Gidron Y: The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci 166: 96-99, 2012.
30. Crimmins EM, Johnston M, Hayward M and Seeman T: Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol 38: 731-734, 2003.
31. Pfleger CC, Flachs EM and Koch-Henriksen N: Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study. Eur J Neurol 17: 1346-1351, 2010.
32. Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, Potashnik G, Lunenfeld E, Schenker JG, Shushan A, Fishman A, Cohen I, Vagman I and Lunenfeld B: Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women. Breast Cancer Res Treat 100: 201-212, 2006.
33. Thong T, Li K, McNames J, Aboy M and Goldstein B: Accuracy of ultra-short heart rate variability measures. Engineering in Medicine and Biology Society. Proc 25th Annual Int Conference of the IEEE 3: 2424-2427, 2003.
34. Nussinovitch U, Elishkevitz KP, Katz K, Nussinovitch M, Segev S, Volovitz B and Nussinovitch N: Reliability of ultra-short ECG indices for heart rate variability. Ann Noninvasive Electrocardiol 16: 117-122, 2011.
35. Hodgart E and Macfarlane PW: 10 second heart rate variability. Comp Cardiol 31: 217-220, 2004.
36. Schipke JD, Pelzer M and Arnold G: Effect of respiration rate on short-term heart rate variability. J Clin Basic Cardiol 2: 92-94, 1999.
37. Poyhonen M, Syvaoja S, Hartikainen J, Ruokonen E and Takala J: The effect of carbon dioxide, respiratory rate and tidal volume on human heart rate variability. Acta Anaesthesiol Scand 48: 93-101, 2004.
38. Strauss-Blasche G, Moser M, Voica M, McLeod DR, Klammer N and Marktl W: Relative timing of inspiration and expiration affects respiratory sinus arrhythmia. Clin Exp Pharmacol Physiol 27: 601-606, 2000.
39. Brown JK, Cooley ME, Chernecky C and Sarna L: A symptom cluster and sentinel symptom experienced by women with lung cancer. Oncol Nurs Forum 38: E425-E435, 2011.
40. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS and Gulsvik A: Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 173: 1316-1325, 2006.
41. Katona PG and Jih F: Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol 39: 801-805, 1975.
42. Cassart M, Pettiaux N, Gavenois PA, Pavia M and Estenne M: Effect of chronic hyperinflation on diaphragm length and surface area. Am J Respir Crit Care Med 156: 504-508, 1997.
43. Alifano M, Falcoz PE, Seegers V, Roche N, Schussler O, Younes M, Antonacci F, Forgez P, Dechartres A, Massard G, Damotte D and Régnard JF: Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 142: 1161-1167, 2011.
44. Hamilton RM, McKechnie PS and Macfarlane PW: Can cardiac vagal tone be estimated from the 10-second ECG? Int J Cardiol 95: 109-115, 2004.
45. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA and Kromhout D: Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 145: 899-908, 1997.
46. O'Donnell K, Brydon L, Wright CE and Steptoe A: Self-esteem levels and cardiovascular and inflammatory responses to acute stress. Brain Behav Immun 22: 1241-1247, 2008.
47. Erin N, Akdas Barkan G, Harms JF and Clawson GA: Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Pept 151: 35-42, 2008.
48. Erin N, Boyer PJ, Bonneau RH, Clawson GA and Welch DR: Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res 24: 1003-1009, 2004.
49. Erin N, Duymuş O, Oztürk S and Demir N: Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul Pept 179: 101-108, 2012.